Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of Tirofiban in STEMI-patients.
Dannenberg L, Wolff G, Naguib D, Pöhl M, Zako S, Helten C, Mourikis P, Levkau B, Hohlfeld T, Zeus T, Kelm M, Schulze V, Polzin A. Dannenberg L, et al. Among authors: mourikis p. Int J Cardiol. 2019 Jan 1;274:35-39. doi: 10.1016/j.ijcard.2018.09.052. Epub 2018 Sep 13. Int J Cardiol. 2019. PMID: 30236502
Dose reduction, oral application, and order of intake to preserve aspirin antiplatelet effects in dipyrone co-medicated chronic artery disease patients.
Dannenberg L, Petzold T, Achilles A, Naguib D, Zako S, Helten C, M'Pembele R, Mourikis P, Podsvyadek Y, Grandoch M, Levkau B, Zeus T, Kelm M, Hohlfeld T, Polzin A. Dannenberg L, et al. Among authors: mourikis p. Eur J Clin Pharmacol. 2019 Jan;75(1):13-20. doi: 10.1007/s00228-018-2560-z. Epub 2018 Sep 24. Eur J Clin Pharmacol. 2019. PMID: 30251061
Enhanced Platelet Reactivity under Aspirin Medication and Major Adverse Cardiac and Cerebrovascular Events in Patients with Coronary Artery Disease.
Dannenberg L, Metzen D, Zako S, Pöhl M, Mourikis P, Helten C, Trojovsky K, Naguib D, Konsek D, Knoop B, Ayhan A, Hohlfeld T, Petzold T, Levkau B, Veulemans V, Zeus T, Kelm M, Polzin A. Dannenberg L, et al. Among authors: mourikis p. Pharmacology. 2020;105(1-2):118-122. doi: 10.1159/000503582. Epub 2019 Oct 22. Pharmacology. 2020. PMID: 31639801
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
Petzold T, Thienel M, Dannenberg L, Mourikis P, Helten C, Ayhan A, M'Pembele R, Achilles A, Trojovky K, Konsek D, Zhang Z, Regenauer R, Pircher J, Ehrlich A, Lüsebrink E, Nicolai L, Stocker TJ, Brandl R, Röschenthaler F, Strecker J, Saleh I, Spannagl M, Mayr CH, Schiller HB, Jung C, Gerdes N, Hoffmann T, Levkau B, Hohlfeld T, Zeus T, Schulz C, Kelm M, Polzin A. Petzold T, et al. Among authors: mourikis p. Circ Res. 2020 Feb 14;126(4):486-500. doi: 10.1161/CIRCRESAHA.119.315099. Epub 2019 Dec 20. Circ Res. 2020. PMID: 31859592
Aspirin antiplatelet effects are associated with body weight.
Mourikis P, Zako S, Dannenberg L, Helten C, Naguib D, Hohlfeld T, Petzold T, Levkau B, Zeus T, Kelm M, Polzin A. Mourikis P, et al. Vascul Pharmacol. 2020 Feb-Mar;125-126:106635. doi: 10.1016/j.vph.2019.106635. Epub 2019 Dec 18. Vascul Pharmacol. 2020. PMID: 31862488
56 results